COVID-19 Vaccine AstraZeneca - Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC as approved by the HPRA

Notice type: Advisory

Date: 25/03/2021




Problem Or Issue:

Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC on: Risk of thrombocytopenia and coagulation disorders of COVID-19 Vaccine AstraZeneca

 

Important Safety Information - COVID-19 Vaccine AstraZeneca




« Back